Anthropic acquires Mithril Medicine as it expands drug discovery work

Image: Primary

Published Wednesday, November 11, 2026 · 11:18 PM EST

Anthropic has acquired Mithril Medicine, a one-person drug developer focused on muscular dystrophy, The Economic Times reported. Founder Cody Tranbarger used Claude to coordinate contracts, experiments and work by 11 external laboratories. The company claims one potential drug progressed from conception to mouse trials in less than 18 months. Anthropic has also launched its own drug discovery programs and is collaborating with companies including Generate Biomedicines and BigHat Biosciences. Most of the science remains preclinical. Anthropic anticipates a drug could be ready for human trials in late 2028 if further studies produce promising results.

Sources

The Economic Times

In this story

Anthropic

Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Economic Times and reviewed by the T&B editorial agent team.

Back to Newswire

Keep reading

Full wire

Capital AI

Nebuly raises $21m to expand AI return measurement business

Turin-based Nebuly has raised $21m in a Series A round led by Planven to expand its business measuring financial returns from enterprise AI.

AI Science

MIT technique improves climate AI predictions with less training data

MIT researchers developed a training method that helped AI climate models predict unfamiliar emissions scenarios using less data, MIT News reported.

AI Products

TSMC board approves investment plans for OpenAI and Anthropic

TSMC's board approved plans to invest up to $500 million in OpenAI preferred stock and another $500 million in Anthropic common shares at its expected IPO price, Ars Technica reports, citing Reuters.

AI Products

Microsoft to enable Claude by default for UK Copilot customers

Microsoft will enable Anthropic's Claude models by default for UK Copilot customers from 9 December, The Register reported. Organisations that leave the setting unchanged will be opted in; administrators can still disable it. Anthropic processes the data in the US.

AI Capital

Fractile raises $720 million to develop AI chips and systems

British AI chip startup Fractile has raised a $720 million Series C backed by Britain's Sovereign AI Fund, TechCrunch reported. Thrive Capital, Founders Fund, Lightspeed Venture Partners and Redpoint led the round. The British government put the valuation at over £5 billion.

Capital AI

StitchStudio raises $8M to expand insurance AI agents

StitchStudio announced Wednesday that it raised $8M in a round led by Voyager Capital to expand AI agents for insurance carriers and brokers. Lookout Ventures, Grit Capital Partners and earlier backers ManchesterStory and BrokerTech Fund participated.